Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Pavanello

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Current Opinion in Lipidology|July 4, 2020
Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020Chiara Pavanello, Laura Calabresi
Recent Patents on Cardiovascular Drug Discovery|May 25, 2013
Novel therapeutic strategies for the homozygous familial hypercholesterolemiaGiuliana Mombelli, Chiara Pavanello
Atherosclerosis Plus|May 16, 2023
HDL and chronic kidney diseaseChiara Pavanello, Alice Ossoli
Endocrinology and Metabolism (Seoul, Korea)|June 16, 2016
High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and AtherosclerosisAlice Ossoli, Chiara Pavanello, Laura Calabresi
Annals of Medicine|July 3, 2014
Microsomal transfer protein (MTP) inhibition-a novel approach to the treatment of homozygous hypercholesterolemiaCesare R Sirtori, Chiara Pavanello, Stefano Bertolini
Pharmacological Research|August 27, 2024
Metformin: From diabetes to cancer to prolongation of lifeCesare R Sirtori, Sofia Castiglione, Chiara Pavanello
Annals of Medicine|August 9, 2017
Nutraceutical approaches to metabolic syndromeCesare R Sirtori, Chiara Pavanello, Laura Calabresi, et al.
Atherosclerosis Plus|March 19, 2025
HDL-replacement therapy: From traditional to emerging clinical applicationsCesare Riccardo Sirtori, Giulia Cincotto, Sofia Castiglione, et al.
Current Medicinal Chemistry|March 17, 2018
Dysfunctional HDL as a Therapeutic Target for Atherosclerosis PreventionAlice Ossoli, Chiara Pavanello, Eleonora Giorgio, et al.
Journal of Proteomics|December 12, 2018
A proteomic approach to identify novel disease biomarkers in LCAT deficiencySara Simonelli, Alice Ossoli, Cristina Banfi, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Current Opinion in Lipidology|July 4, 2020
Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020Chiara Pavanello, Laura Calabresi
Recent Patents on Cardiovascular Drug Discovery|May 25, 2013
Novel therapeutic strategies for the homozygous familial hypercholesterolemiaGiuliana Mombelli, Chiara Pavanello
Atherosclerosis Plus|May 16, 2023
HDL and chronic kidney diseaseChiara Pavanello, Alice Ossoli
Endocrinology and Metabolism (Seoul, Korea)|June 16, 2016
High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and AtherosclerosisAlice Ossoli, Chiara Pavanello, Laura Calabresi
Annals of Medicine|July 3, 2014
Microsomal transfer protein (MTP) inhibition-a novel approach to the treatment of homozygous hypercholesterolemiaCesare R Sirtori, Chiara Pavanello, Stefano Bertolini
Pharmacological Research|August 27, 2024
Metformin: From diabetes to cancer to prolongation of lifeCesare R Sirtori, Sofia Castiglione, Chiara Pavanello
Annals of Medicine|August 9, 2017
Nutraceutical approaches to metabolic syndromeCesare R Sirtori, Chiara Pavanello, Laura Calabresi, et al.
Atherosclerosis Plus|March 19, 2025
HDL-replacement therapy: From traditional to emerging clinical applicationsCesare Riccardo Sirtori, Giulia Cincotto, Sofia Castiglione, et al.
Current Medicinal Chemistry|March 17, 2018
Dysfunctional HDL as a Therapeutic Target for Atherosclerosis PreventionAlice Ossoli, Chiara Pavanello, Eleonora Giorgio, et al.
Journal of Proteomics|December 12, 2018
A proteomic approach to identify novel disease biomarkers in LCAT deficiencySara Simonelli, Alice Ossoli, Cristina Banfi, et al.
Pageof 7